3 ms·
This is a bit confused with different currencies being used with implied ordering... USD 0.82 -> €1.00 Oxford/AstraZeneca: €1.78 -Johnson & Johnson: US$8.50
by angry_octet 6y ago
This is a bit confused with different currencies being used with implied ordering...
USD 0.82 -> €1.00
Oxford/AstraZeneca: €1.78
-Johnson & Johnson: US$8.50 €6.97
-Sanofi/GSK: €7.56
-CureVac: €10
-BioNTech/Pfizer: €12
-Moderna: US$18 €14.76
- kurthr 6y agoI'd go one step further and point out that J&J also requires only one shot (assuming they can reach high effectiveness ~90% without significant side effects <100ppm). Not only is there reduced logistical challenge which is easily >$10, but the others are only listed at half the effective price since they have to be given twice 3-4 weeks apart!
- angry_octet 6y agoAlthough there is significant consideration being given to giving only one dose of Pfizer/Moderna, i.e. a health system operated stage 4 trial. At least I hope they do the effort to make it a proper trial, it might be a shambolic politically driven cluster fuck. (Do you get an 'immunity passport' with only one shot? Which vaccines do countries recognize? The Russian and Chinese ones with NO clinical trial data?)
- smileysteve 6y agoNobody needs an immunity passport once a location is back below community spread. Once a location has a low local positivity rate, testing and contact tracing are effective again. This should start occurring naturally once essential workers are vaccinated; then any partial lockdown or additional vaccination should destroy community spread.
- angry_octet 6y agoPractically speaking, countries will likely require proof of immunisation for international travel. Maybe not the US, though I wouldn't go there without it. I'd also expect it would become expensive to get travel insurance without immunisation.